Atezolizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Nasopharyngeal Cancer. According to GlobalData, Phase II drugs for Nasopharyngeal Cancer have a 37% ...

Tislelizumab, in combination with chemotherapy as a first-line treatment for patients with recurrent or metastatic nasopharyngeal cancer (NPC). It is also indicated to treat cancers associated with ...

Background: Nasopharyngeal carcinoma (NPC) is a type of malignant tumors commonly found in Southeast Asia and China, with insidious onset and clinical symptoms. N6-methyladenosine (m6A) modification ...

The symptoms caused by intracranial tumors extend over months or years in the great majority of cases. For this reason, brain tumors would not be expected to appear in the records of the medical ...

1GuangDong Provincial Key Laboratory of Tumor Immunotherapy, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.

The nerves of the head and face—the cranial nerves—are unique in that they originate in the brain ... The posterior nasal branches innervate the mucous membranes in the nasal passages. The pharyngeal ...

Head and neck cancer comprises a group of biologically similar cancers that start in the lip, oral cavity (mouth), nasal cavity (inside the nose), paranasal sinuses, pharynx and larynx.

According to the Mayo Clinic, nasopharyngeal carcinoma is a type of cancer that develops on the nasopharynx, which is located in the upper part of the throat and sits behind the nose. Its main ...